Navigation Links
United Therapeutics Reports Third Quarter 2007 Financial Results
Date:11/1/2007

- Record Total Revenues of $59.0 Million, Up 46 Percent Over Third Quarter

2006 - Third Quarter EPS of $0.70 per Basic Share, or $0.66 per Diluted Share - Third Quarter EBITDASO of $1.26 per Basic Share, or $1.19 per Diluted

Share

SILVER SPRING, Md., Nov. 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2007.

Total revenues for the third quarter of 2007 were $59.0 million, up 46% from $40.4 million for the third quarter of 2006. Pro forma earnings corresponding to our Company-wide Milestone measuring GAAP earnings before income taxes, depreciation, amortization and stock option expenses (EBITDASO), were $26.6 million for the third quarter of 2007, up 35% from $19.7 million for the third quarter of 2006. Net income for the third quarter of 2007 was $14.8 million, or $0.70 per basic share, up 74% from $8.5 million, or $0.37 per basic share, in the third quarter of 2006. Gross margins from sales were $52.2 million in the third quarter of 2007, as compared to $36.2 million in the third quarter of 2006. The increases in revenues and gross margins resulted primarily from growth in sales of our lead product, Remodulin.

"It is pretty gratifying for us to be on the line of approximately 40% annual growth in revenues for almost five years now," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "Our trailing twelve month revenues of $196.9 million are 37% above that of the preceding period. Plus, this is our 13th profitable quarter overall, and our 14th straight profitable quarter disregarding
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Inacom Education earns Wisconsin membership in United Training
2. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... July 26, 2014 Canada Endoscopy ... market data on the Canada Endoscopy Visualization Systems ... US dollars, volume (in units) and average prices ... Endoscopy Visualization Systems, Mid-Range Endoscopy Visualization Systems and ... at http://www.marketresearchreports.biz/analysis/213254 . , The report also ...
(Date:7/25/2014)... July 26, 2014 "Ischemic Stroke ... 2014" provides data on the Ischemic Stroke and ... elemental information and data relating to the clinical ... View full global Ischemic Stroke Research Report 2014 ... overview of the trial numbers and their recruitment ...
(Date:7/25/2014)... 25, 2014 Amgen (NASDAQ: AMGN ... a $0.61 per share dividend for the third quarter ... 5, 2014, to all stockholders of record as of ... About Amgen Amgen is committed to unlocking ... illnesses by discovering, developing, manufacturing and delivering innovative human ...
(Date:7/25/2014)... MA -- Trillions of bacteria live in each person,s ... help digest food and stave off harmful infections, but ... , To help shed light on the role of ... associate professor Eric Alm recently tracked fluctuations in the ... year. The findings, described in the July 25 issue ...
Breaking Biology Technology:Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Monitoring the rise and fall of the microbiome 2Monitoring the rise and fall of the microbiome 3
... , Evelyn McGown, Ph.D., Jinfang Liao, M.D., Ph.D., Molecular ... Olivier Dery, BD Biosciences Clontech, Palo Alto, CA. ... INTRODUCTION , Proteins inside eukaryotic ... balance between synthesis and degradation. Whereas protein synthesis is ...
... A. Gagne, E. Robitaille, M. Harvey, J.-A. St. Pierre, D. ... Introduction , High throughput ... process is typically highly automated and can provide screening rates over 100,000 ... simple, preferably mix and read type assays, where all reagents necessary to ...
... , This study demonstrated ... platform for a helicase functional assay. Helicase activity was measured on ... the oligos was biotinylated; the other was 5' end-labeled with [ ... a [ 33 P]-biotinylated DNA duplex substrate, then immobilized on the ...
Cached Biology Technology:Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers 2Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers 3Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers 4Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers 5Receptor Binding Assays using Fluorescence Polarization Detection: the [FP]2TM Characterized Tracers 2Receptor Binding Assays using Fluorescence Polarization Detection: the [FP]2TM Characterized Tracers 3Receptor Binding Assays using Fluorescence Polarization Detection: the [FP]2TM Characterized Tracers 4Receptor Binding Assays using Fluorescence Polarization Detection: the [FP]2TM Characterized Tracers 5Receptor Binding Assays using Fluorescence Polarization Detection: the [FP]2TM Characterized Tracers 6Evaluation of FlashPlate in a Helicase Assay 2Evaluation of FlashPlate in a Helicase Assay 3
(Date:7/25/2014)... of Adelaide has opened the way for the development of ... In Australia, annual barley production is second only to wheat ... of the most important diseases of barley. , Senior Research ... of special growths on the cell walls of barley plants ... , The research, by the ARC Centre of Excellence in ...
(Date:7/25/2014)... (SB) is a complex congenital central nervous system ... of the neural tubes during the embryonic phase. ... and fecal incontinence and neurocognitive retardation. Such problems ... of life. Researchers at Ankara Physical Medicine and ... functional performance in children with SB, using the ...
(Date:7/25/2014)... reach puberty is influenced by ,imprinted genes,a subset of genes ... This is the first evidence that imprinted genes can ... this study were published today in the journal Nature ... is a marker for the timing of puberty in females. ... between girls, is an inherited trait, and is linked to ...
Breaking Biology News(10 mins):New hope for powdery mildew resistant barley 2Could age of first period influence development of diseases in older women? 2
... the International Symposium " Nature and Governance Biodiversity Data, Science, ... 11 to 12 February. The symposium aimed at clarifying and popularizing ... Meeting held from 13 to 15 February 2013. The ... and brought together high-ranking speakers and guests from across the world ...
... chair!" That command given by countless parents to their ... a robot that is actually a computerized model of a ... a University of Iowa research program. That,s because a ... to accurately predict the role posture plays in transferring the ...
... A team of UCLA-led researchers has identified a protein ... as a weapon against deadly human pathogenic viruses such ... designated "priority pathogens" for national biosecurity purposes by the ... In a study published in the January issue ...
Cached Biology News:Virtual vehicle vibrations 2Newly identified natural protein blocks HIV, other deadly viruses 2
Mouse monoclonal antibody raised against a partial recombinant AAAS. NCBI Entrez Gene ID = AAAS...
... Cosmid Cloning Kit enables you to prepare, ... unbiased primary cosmid library of genomic DNA ... sublibraries. High efficiency cosmid library construction is ... protocols. First, genomic DNA is randomly sheared ...
Mouse monoclonal antibody raised against a partial recombinant EBI3. NCBI Entrez Gene ID = EBI3...
... VersaDoc MP 4000 System is a ... system capable of supporting a wide ... chemiluminescence, densitometry, and chemiflourescence. Red, ... imaging of multiplexed fluorescent samples, reducing ...
Biology Products: